أخبار السوق

0 0 0

المصدر: Proactive Investors وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Persimmon keeps dividend flat as market set to 'remain challenging' into next year

Persimmon PLC (LSE:PSN) kept its dividend flat as it reported double-digit growth in first-half profits and completions but flagged signs of softer demand in the second half. The FTSE 100 housebuilder posted interim results showing underlying operating profit rose 10% to £189.1 million, although the margin narrowed by 30 basis points to 12.8%.

الرموز ذات الصلة 1

P PSMMY PSMMY

المصدر: Proactive Investors

0 0 0

المصدر: Seeking Alpha وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

DBS Group Holdings Ltd (DBSDY) Q2 2026 Earnings Call Transcript

الرموز ذات الصلة 1

D DBSDY DBSDY

المصدر: Seeking Alpha

0 0 0

المصدر: MarketBeat وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

ONE Group Hospitality Q2 Earnings Call Highlights

ONE Group Hospitality NASDAQ: STKS reported second-quarter revenue declined from a year earlier, as planned restaurant portfolio optimization and a delayed New York City relocation weighed on reported sales. However, the company said comparable sales, transactions and restaurant-level margins improved across its operating segments.

الرموز ذات الصلة 1

S STKS STKS

المصدر: MarketBeat

0 0 0

المصدر: CNBC وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Google is expanding its AI empire — and losing the people who built it

Google's cloud boom is testing the company's commitment to frontier AI as commercial returns take priority. Jeff Dean's departure and Demis Hassabis' move away from daily management of DeepMind add to questions about Google's ability to retain top talent and stay at the frontier.

الرموز ذات الصلة 1

G GOOG GOOG

المصدر: CNBC

0 0 0

المصدر: Seeking Alpha وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Eli Lilly Q2: Strong Results Further Strengthen The Investment Thesis

Eli Lilly remains a buy after Q2, with robust revenue growth and strong performance from Mounjaro and Zepbound. LLY raised 2026 revenue guidance to $85–87 billion, driven by volume gains despite price declines, and reinforced margin expansion. Retatrutide is a key medium-term catalyst, with a BLA submission planned for Q1 2027 and potential in new therapeutic areas.

الرموز ذات الصلة 1

L LLY LLY

المصدر: Seeking Alpha

0 0 0

المصدر: Accesswire وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Valeura Energy Inc. Announces Record Operational and Financial Performance in Q2 2026

CALGARY, AB / ACCESS Newswire / August 6, 2026 / Valeura Energy Inc. (TSX:VLE)(OTCQX:VLERF) ("Valeura" or the "Company") reports its unaudited financial and operating results for the three and six month periods ended 30 June 2026. The complete quarterly reporting package for the Company, including the unaudited financial statements (the "Interim Financial Statement") and associated management's discussion and analysis ("MD&A") are being filed on SEDAR+ at www.sedarplus.caand posted the Company's website at www.valeuraenergy.com.

الرموز ذات الصلة 1

V VLE VLE

المصدر: Accesswire

0 0 0

المصدر: Seeking Alpha وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript

الرموز ذات الصلة 1

R RXST RXST

المصدر: Seeking Alpha

0 0 0

المصدر: Reuters وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

OpenAI asks US judge to dismiss Apple's trade secrets case

OpenAI asked a U.S. judge on Wednesday to dismiss Apple's lawsuit accusing it and two former ‌Apple employees of misappropriating the iPhone maker's trade secrets to benefit the ChatGPT maker's foray into consumer hardware.

الرموز ذات الصلة 1

AAPL Apple Inc.

المصدر: Reuters

0 0 0

المصدر: PRNewsWire وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Collaboration combines Odyssey's disease biology expertise with Evotec's AI-enabled discovery platform, advanced screening capabilities and proprietary compound libraries to support advancement of Odyssey's discovery-stage programs Evotec to deliver validated hit series across multiple high-value targets for large inflammatory and autoimmune diseases with high unmet medical need HAMBURG, Germany, Aug. 6, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced that it has entered a strategic R&D collaboration with Odyssey Therapeutics, Inc. (NASDAQ: ODTX) to discover potential new treatments in autoimmune and inflammatory diseases. Under the agreement, Odyssey will leverage Evotec's integrated data-driven discovery platform, advanced screening capabilities and AI-enabled data science technologies to discover and validate differentiated small molecule drug candidates across multiple high-value disease targets.

الرموز ذات الصلة 1

E EVO EVO

المصدر: PRNewsWire

0 0 0

المصدر: WSJ وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Arms Maker Rheinmetall Trims Sales Guidance After Germany Scraps Frigate Project

The company expects annual sales between $15.83 billion to $16.41 billion, guidance which remains above what it reported last year.

الرموز ذات الصلة 1

R RNMBF RNMBF

المصدر: WSJ

0 0 0

المصدر: Seeking Alpha وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

SoundHound AI, Inc. (SOUN) Q2 2026 Earnings Call Transcript

الرموز ذات الصلة 1

S SOUN SOUN

المصدر: Seeking Alpha

0 0 0

المصدر: Proactive Investors وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Diversified Energy turns driller in shift away from acquisition-led growth

Diversified Energy Company PLC (LSE:DEC, NYSE:DEC, FRA:DG20), the Alabama-based gas producer listed in London and New York, is to start drilling its own wells, a departure from the acquisition-led model that built the company. The company said it would launch a one-rig operated development programme in Oklahoma in the second half of this year, spending $35 million to $50 million.

الرموز ذات الصلة 1

D DEC DEC

المصدر: Proactive Investors

0 0 0

المصدر: Seeking Alpha وكالة أنباء

قبل شهر واحد

الأسهم أهمية متوسطة

Amkor Technology's Valuation Lags Its Growth

Amkor Technology is rated Strong Buy, with record Q2 2026 performance and robust multi-year growth drivers from AI and advanced packaging. Q2 revenue surged 26% YoY to $1.90B, gross margin improved to 16.8%, and utilization rates reached the high 70s, with several lines at full capacity. Long-term contracts with TSMC and NVIDIA enhance planning visibility, support advanced packaging growth, and underpin confidence in future capacity loading.

الرموز ذات الصلة 1

A AMKR AMKR

المصدر: Seeking Alpha

0 0 0